Intracellular antibody-caspase-mediated cell killing: an approach for application in cancer therapy.
about
Specific in vivo knockdown of protein function by intrabodiesTargeting the apoptosis pathway in hematologic malignanciesDe novo production of diverse intracellular antibody libraries.Generation of anti-TLR2 intrabody mediating inhibition of macrophage surface TLR2 expression and TLR2-driven cell activation.Selection of complementary single-variable domains for building monoclonal antibodies to native proteinsIntrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformationFine epitope mapping of the central immunodominant region of nucleoprotein from Crimean-Congo hemorrhagic fever virus (CCHFV)Caspases: potential targets for regulating cell death.Apoptosis-based therapies and drug targets.Knockdown of CREB3/Luman by shRNA in Mouse Granulosa Cells Results in Decreased Estradiol and Progesterone Synthesis and Promotes Cell Proliferation.Caspase activation, sialidase release and changes in sialylation pattern of recombinant human erythropoietin produced by CHO cells in batch and fed-batch cultures.Fibrils colocalize caspase-3 with procaspase-3 to foster maturation.Immunosympathectomy as the first phenotypic knockout with antibodies.Blocking translocation of cell surface molecules from the ER to the cell surface by intracellular antibodies targeted to the ER.State of the art in tumor antigen and biomarker discovery.Advances in the understanding of the Fc gamma receptors-mediated autoantibodies uptake.LMO2 at 25 years: a paradigm of chromosomal translocation proteins.Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.Targeting immune effector molecules to human tumor cells through genetic delivery of 5T4-specific scFv fusion proteins.Therapeutic Antibodies against Intracellular Tumor AntigensChromosomal translocation master genes, mouse models and experimental therapeutics.
P2860
Q26801077-FA6B1437-72AC-48FC-8DA2-EBFAA40161A8Q27024422-2C692533-6B89-4FD0-BA60-1D21CEFFE058Q30887786-EF7DA7F9-B897-464F-A5D3-25EA106622D7Q30980638-82E3348D-D516-4CA8-B76B-7AFF149BDB12Q33408086-6FEBF338-DA68-42A2-8001-F1F8D9CE9E1EQ34775170-B86209B3-8B09-4BE2-A334-0B55E92E8797Q35387209-C9FE96D6-0309-4223-8844-21157A3C88F1Q35985520-66CF8497-E368-4B30-9DF1-F317A204CEA0Q36017772-762EBED7-2DF9-47F2-95D0-C6496D2F5CF8Q36223723-DCA1A768-C98A-4301-89AA-061416E3B5F6Q36254996-5D824416-976C-48CC-B32D-78E81F4E5C26Q36286189-9ED2AD13-EE5E-4FB6-8ED2-B8D2442D5BFBQ36729840-670C20C4-C80D-449D-A9A3-759A61085024Q36762625-6A51CEE1-BA48-432E-83AC-BF3567541E5EQ37132800-60726D73-7221-4203-B3C7-796557322780Q37747198-D2659DAC-2C0A-4588-BB3C-77700EF8C3B0Q38537084-0BA8B9FA-963D-4DDB-8682-C178B6B3425FQ39864280-C9CB7D8D-A25B-475F-B34E-797FD9BFFB53Q40696514-7FFD41FC-1A54-48FC-A7BB-33A59D4FDC7BQ41462883-001A0B75-CB21-4FA0-87A8-ADB2ED015A46Q52128463-0C9B4D3A-9232-4BDF-A530-41AC607C060F
P2860
Intracellular antibody-caspase-mediated cell killing: an approach for application in cancer therapy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Intracellular antibody-caspase ...... application in cancer therapy.
@ast
Intracellular antibody-caspase ...... application in cancer therapy.
@en
type
label
Intracellular antibody-caspase ...... application in cancer therapy.
@ast
Intracellular antibody-caspase ...... application in cancer therapy.
@en
prefLabel
Intracellular antibody-caspase ...... application in cancer therapy.
@ast
Intracellular antibody-caspase ...... application in cancer therapy.
@en
P2860
P356
P1476
Intracellular antibody-caspase ...... application in cancer therapy
@en
P2093
P2860
P304
12266-12271
P356
10.1073/PNAS.97.22.12266
P407
P577
2000-10-01T00:00:00Z